Sinclair R - Search Results

1

A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis.

Zhang C, Yan K, Diao Q, Guo Q, Jin H, Yang S, Chen X, Lei T, Wu J, Yu H, Zheng M, Gao X, Sinclair R, Zhu Y, Xu Q, Xu J. Zhang C, et al. Among authors: sinclair r. J Am Acad Dermatol. 2022 Jul;87(1):95-102. doi: 10.1016/j.jaad.2022.01.005. Epub 2022 Jan 10. J Am Acad Dermatol. 2022. PMID: 35026342 Clinical Trial.

2

Hidradenitis suppurativa responding to treatment with infliximab.

Lasocki A, Sinclair R, Foley P, Saunders H. Lasocki A, et al. Among authors: sinclair r. Australas J Dermatol. 2010 Aug;51(3):186-90. doi: 10.1111/j.1440-0960.2010.00623.x. Australas J Dermatol. 2010. PMID: 20695857

3

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.

Sinclair RD. Sinclair RD. Int J Dermatol. 2018 Jan;57(1):104-109. doi: 10.1111/ijd.13838. Epub 2017 Dec 12. Int J Dermatol. 2018. PMID: 29231239

4

Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.

Bokhari L, Sinclair R. Bokhari L, et al. Among authors: sinclair r. Int J Dermatol. 2018 Dec;57(12):1464-1470. doi: 10.1111/ijd.14192. Epub 2018 Aug 30. Int J Dermatol. 2018. PMID: 30160787 Clinical Trial.

5

Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety.

Lai VWY, Chen G, Gin D, Sinclair R. Lai VWY, et al. Among authors: sinclair r. J Am Acad Dermatol. 2019 Sep;81(3):694-701. doi: 10.1016/j.jaad.2019.04.053. Epub 2019 Apr 30. J Am Acad Dermatol. 2019. PMID: 31048013 Clinical Trial.

6

Successful treatment of refractory folliculitis decalvans with secukinumab.

Ismail FF, Sinclair R. Ismail FF, et al. Among authors: sinclair r. Australas J Dermatol. 2020 May;61(2):165-166. doi: 10.1111/ajd.13190. Epub 2019 Oct 24. Australas J Dermatol. 2020. PMID: 31646619 No abstract available.

7

Response of alopecia areata of the beard to oral tofacitinib.

Kerkemeyer KLS, John JM, Sinclair R, Bhoyrul B. Kerkemeyer KLS, et al. Among authors: sinclair r. J Am Acad Dermatol. 2020 May;82(5):1228-1230. doi: 10.1016/j.jaad.2019.10.058. Epub 2019 Oct 31. J Am Acad Dermatol. 2020. PMID: 31678329 No abstract available.

8

Tildrakizumab for treatment of refractory pyoderma gangrenosum of the penis and polymyalgia rheumatica: Killing two birds with one stone.

John JM, Sinclair RD. John JM, et al. Australas J Dermatol. 2020 May;61(2):170-171. doi: 10.1111/ajd.13196. Epub 2019 Nov 14. Australas J Dermatol. 2020. PMID: 31729012 No abstract available.

9

Treatment of chronic alopecia areata with tildrakizumab: an open-label pilot study.

Kerkemeyer KLS, Sinclair R. Kerkemeyer KLS, et al. Among authors: sinclair r. Int J Dermatol. 2020 May;59(5):e136-e137. doi: 10.1111/ijd.14826. Epub 2020 Mar 3. Int J Dermatol. 2020. PMID: 32124974 Clinical Trial. No abstract available.

10

Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients.

Ismail FF, Meah N, Trindade de Carvalho L, Bhoyrul B, Wall D, Sinclair R. Ismail FF, et al. Among authors: sinclair r. J Am Acad Dermatol. 2020 Nov;83(5):1478-1479. doi: 10.1016/j.jaad.2020.03.034. Epub 2020 Mar 22. J Am Acad Dermatol. 2020. PMID: 32213304 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

973 results

Search Page

Filters